Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hepatitis, Alcoholic
|
1 | 0.557 | 0.720 | 22 | 43928847 | missense variant | C/G | snv | 0.28 | 0.22 | 0.020 | 1.000 | 2 | 2016 | 2017 | ||||
Chronic Liver Failure
|
1 | 0.557 | 0.720 | 22 | 43928847 | missense variant | C/G | snv | 0.28 | 0.22 | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||
POLYDACTYLY, POSTAXIAL, WITH PROGRESSIVE MYOPIA
|
1 | 0.557 | 0.720 | 22 | 43928847 | missense variant | C/G | snv | 0.28 | 0.22 | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||
Premenstrual syndrome
|
1 | 0.557 | 0.720 | 22 | 43928847 | missense variant | C/G | snv | 0.28 | 0.22 | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||
Renal tubular injury
|
1 | 0.557 | 0.720 | 22 | 43928847 | missense variant | C/G | snv | 0.28 | 0.22 | 0.010 | 1.000 | 1 | 2020 | 2020 | ||||
alcohol-related liver disease
|
2 | 0.557 | 0.720 | 22 | 43928847 | missense variant | C/G | snv | 0.28 | 0.22 | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||
End Stage Liver Disease
|
3 | 0.557 | 0.720 | 22 | 43928847 | missense variant | C/G | snv | 0.28 | 0.22 | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||
Obesity, Visceral
|
3 | 0.557 | 0.720 | 22 | 43928847 | missense variant | C/G | snv | 0.28 | 0.22 | 0.010 | 1 | 2010 | 2010 | |||||
Portal cirrhosis
|
4 | 0.557 | 0.720 | 22 | 43928847 | missense variant | C/G | snv | 0.28 | 0.22 | 0.700 | 1.000 | 1 | 2015 | 2015 | ||||
Viral hepatitis
|
5 | 0.557 | 0.720 | 22 | 43928847 | missense variant | C/G | snv | 0.28 | 0.22 | 0.020 | 1.000 | 2 | 2013 | 2018 | ||||
HCV coinfection
|
5 | 0.557 | 0.720 | 22 | 43928847 | missense variant | C/G | snv | 0.28 | 0.22 | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||
Chronic viral hepatitis
|
8 | 0.557 | 0.720 | 22 | 43928847 | missense variant | C/G | snv | 0.28 | 0.22 | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||
Posterior subcapsular cataract
|
9 | 0.557 | 0.720 | 22 | 43928847 | missense variant | C/G | snv | 0.28 | 0.22 | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||
22q13.3 Deletion Syndrome
|
10 | 0.557 | 0.720 | 22 | 43928847 | missense variant | C/G | snv | 0.28 | 0.22 | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||
Hepatitis, Chronic
|
10 | 0.557 | 0.720 | 22 | 43928847 | missense variant | C/G | snv | 0.28 | 0.22 | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||
Respiratory Tract Infections
|
10 | 0.557 | 0.720 | 22 | 43928847 | missense variant | C/G | snv | 0.28 | 0.22 | 0.010 | 1.000 | 1 | 2020 | 2020 | ||||
Chronic liver disease
|
14 | 0.557 | 0.720 | 22 | 43928847 | missense variant | C/G | snv | 0.28 | 0.22 | 0.030 | 1.000 | 3 | 2015 | 2018 | ||||
Adult Hepatocellular Carcinoma
|
14 | 0.557 | 0.720 | 22 | 43928847 | missense variant | C/G | snv | 0.28 | 0.22 | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||
Liver Cirrhosis, Alcoholic
|
15 | 0.557 | 0.720 | 22 | 43928847 | missense variant | C/G | snv | 0.28 | 0.22 | 0.790 | 0.800 | 10 | 2010 | 2017 | ||||
Insulin resistance syndrome
|
15 | 0.557 | 0.720 | 22 | 43928847 | missense variant | C/G | snv | 0.28 | 0.22 | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||
Prediabetes syndrome
|
16 | 0.557 | 0.720 | 22 | 43928847 | missense variant | C/G | snv | 0.28 | 0.22 | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||
Nonalcoholic Steatohepatitis
|
17 | 0.557 | 0.720 | 22 | 43928847 | missense variant | C/G | snv | 0.28 | 0.22 | 0.100 | 1.000 | 13 | 2010 | 2019 | ||||
Childhood Hepatocellular Carcinoma
|
17 | 0.557 | 0.720 | 22 | 43928847 | missense variant | C/G | snv | 0.28 | 0.22 | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||
Alcoholic Liver Diseases
|
20 | 0.557 | 0.720 | 22 | 43928847 | missense variant | C/G | snv | 0.28 | 0.22 | 0.100 | 1.000 | 14 | 2011 | 2019 | ||||
Liver Failure
|
20 | 0.557 | 0.720 | 22 | 43928847 | missense variant | C/G | snv | 0.28 | 0.22 | 0.010 | 1.000 | 1 | 2019 | 2019 |